Monoclonal antibodies for viral infections: where to, and how?

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1575, 2007-01, pp. : 2-2

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Role of Pharmacoeconomic Analysis in R&D Decision Making: When, Where, How?

By Paul Miller

PharmacoEconomics, Vol. 23, Iss. 1, 2005-01 ,pp. : 1-12

Adis International

Access to resources Recommend Favorite

Switching Between Second-Generation Antipsychotics: Why and How?

By Monika Edlinger Susanne Baumgartner Nadja Eltanaihi-Furtmüller Martina Hummer W. Wolfgang Fleischhacker

CNS Drugs, Vol. 19, Iss. 1, 2005-01 ,pp. : 27-42

Adis International

Access to resources Recommend Favorite

Biological Therapy in the Management of Recent-Onset Crohn's Disease: Why, When and How?

By Löwenberg Mark

Drugs, Vol. 66, Iss. 11, 2006-01 ,pp. : 1431-1439

Adis International

Access to resources Recommend Favorite

Where to for WHO?

Inpharma, Vol. 1, Iss. 1547, 2006-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Increased risk of infections with alemtuzumab?

Inpharma, Vol. 1, Iss. 1545, 2006-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite